AD: |
Alzheimer’s disease |
AGE: |
advanced-glycation end product |
AGE–BSA: |
AGE–bovine serum albumin |
AGE–HSA: |
AGE–human serum albumin |
AGE-R: |
AGE receptors |
α-SMA: |
α-smooth muscle actin |
AMD: |
aging-related macular degeneration |
ARE: |
antioxidant responsive element |
CEL: |
Nε-(carboxyethyl)lysine |
CML: |
Nε-(carboxymethyl)lysine |
CVD: |
cardiovascular disease |
DM: |
diabetes mellitus |
DN: |
diabetic nephropathy |
DPP4: |
dipeptidyl peptidase 4 |
DR: |
diabetic retinopathy |
GIP-1: |
glucose-dependent insulinotropic peptidase-1 |
GLO: |
glyoxalase |
GLP-1: |
glucagon-like peptide-1 |
GO: |
glyoxal |
GOLD: |
glyoxal-lysine dimer |
HMGB1: |
high-mobility group box-1 |
HUVEC: |
human umbilical vein-derived endothelial cell |
IFN: |
interferon |
IL: |
interleukin |
ILK: |
integrin-linked kinase |
ISRE: |
interferon-stimulated response element |
Med diet: |
Mediterranean diet |
MFB: |
myofibroblast |
MGO: |
methylglyoxal |
MO: |
morbid obesity |
MOLD: |
methylglyoxal-lysine dimer |
MPO: |
neutrophil myeloperoxidase |
MR: |
Maillard reaction |
NE: |
neutrophil elastase |
Nrf2: |
nuclear factor erythroid 2-related factor 2 |
NRP-1: |
neuropilin-1 |
OX: |
oxidative damage |
OPN: |
osteopontin |
OS: |
oxidative stress |
PD: |
Parkinson’s disease |
RAA: |
renin-angiotensin-aldosterone |
RAGE: |
receptor for AGE |
RCO: |
reactive carbonyl compound |
RNI: |
reactive nitrogen intermediates |
ROS: |
reactive oxygen species |
RPEC: |
retinal pigmented epithelial cell |
SAF: |
skin autofluorescence |
Sp1: |
specificity protein 1 |
sRAGE: |
soluble form RAGE |
Th: |
helper T lymphocyte |
TNF-α: |
tumor necrosis factor –α |
Treg: |
regulatory T lymphocyte |
VEGF: |
vascular endothelial cell growth factor |
VSMC: |
vascular smooth muscle cell |